By Trefis Team
Publication Date: 2025-11-18 16:16:00
Close-up of a sign with logo at the headquarters of technology company Synopsys in Silicon Valley, Mountain View, California, May 3, 2019. (Photo by Smith Collection/Gado/Getty Images)
Getty Images
ORCL and CRM are Synopsis Competitors in the application software industry that have:
1) A lower valuation (P/OpInc) compared to Synopsys stock
2) However, they have higher sales and operating income growth.
This discrepancy between valuation and performance suggests that buying ORCL and CRM stock could be more beneficial than buying SNPS share
Individual stocks may experience volatility and lead to selling, but strategic allocation and diversification will keep you invested. Our wealth management partner based in Boston Asset division The strategy is specifically designed for this purpose.
Important key figures in comparison
OpInc = operating income, P/OpInc = price to operating income ratio
But do these numbers provide a complete picture? To read Buy or sell SNPS shares to determine whether Synopsys…
